NES and neoplasm: In an attempt to kill both the differentiated and tumor initiating NB cells, this study demonstrated that a nestin targeted engineered clinically safe oncolytic virus (rQNestin34.5) promoted a profound cell death of both bulk and tumor initiating tumorsphere-derived NB cells.